ADALIMUMAB-ATTO for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 43 adverse event reports in the FDA FAERS database where ADALIMUMAB-ATTO was used for Psoriasis.
Most Reported Side Effects for ADALIMUMAB-ATTO
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Device difficult to use | 328 | 28.6% | 0 | 4 |
| Product storage error | 279 | 24.4% | 0 | 0 |
| Drug dose omission by device | 219 | 19.1% | 0 | 4 |
| Circumstance or information capable of leading to medication error | 194 | 16.9% | 0 | 0 |
| Accidental exposure to product | 123 | 10.7% | 0 | 0 |
| Injection site pain | 100 | 8.7% | 0 | 0 |
| Intercepted product administration error | 75 | 6.5% | 0 | 0 |
| Wrong technique in product usage process | 69 | 6.0% | 0 | 0 |
| Drug ineffective | 48 | 4.2% | 2 | 13 |
| Off label use | 47 | 4.1% | 2 | 13 |
| Product communication issue | 46 | 4.0% | 0 | 1 |
| Pain | 33 | 2.9% | 2 | 15 |
| Rheumatoid arthritis | 33 | 2.9% | 2 | 15 |
| Device use error | 29 | 2.5% | 0 | 0 |
| Arthralgia | 25 | 2.2% | 2 | 12 |
Other Indications for ADALIMUMAB-ATTO
Product used for unknown indication (660)
Rheumatoid arthritis (138)
Inflammatory bowel disease (69)
Crohn's disease (58)
Psoriatic arthropathy (56)
Colitis ulcerative (26)
Ankylosing spondylitis (19)
Arthritis (16)
Hidradenitis (14)
Uveitis (9)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)